Since 2000, Novo Nordisk—a global healthcare company with more than 90 years of innovation and leadership in diabetes care—has been a valued JDRF partner. In that time, the company has contributed more than an amazing $10 million for type 1 diabetes (T1D) research through their global support of JDRF. Novo Nordisk shows its generosity in many ways—including funding TypeOneNation.org, the online T1D resources community, co-sponsoring JDRF T1D Care Kits for newly diagnosed adults and sponsoring JDRF Children’s Congress in support of our advocacy efforts. Their support of JDRF’s international affiliates extends to One Walk®, Gala and research activities. Novo Nordisk is also a valued member of the JDRF Industry Advisory Panel.
Novo Nordisk also helps advance JDRF’s mission by supporting:
- Local Chapter support through the Walk and Gala
- JDRF Ride to Cure Diabetes through a national corporate Ride team
- T1D Performance in Exercise and Knowledge (PEAK) program
- TypeOneNation Summits
We thank Novo Nordisk for all they do to help JDRF create a world without T1D.